×
Request Free Sample ×
Sleeping Bruxism Treatment Market Research Report—Global Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Sleeping Bruxism Treatment Market

ID: MRFR/HC/3979-CR
130 Pages
Rahul Gotadki
December 2021

Sleeping Bruxism Treatment Market Research Report Information by Type (Primary Bruxism, Secondary Bruxism), by Treatment (Dental Approaches, Medication), by Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease (GERD), Malocclusion, Sleep Paralysis), by Patient Type (Pediatric, Adult), by End User (Hospitals & Clinics, Dental Clinics) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Sleeping Bruxism Treatment Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Sleeping Bruxism Treatment Market Summary

As per MRFR analysis, the Sleeping Bruxism Treatment Market was estimated at 616.69 USD Million in 2024. The Sleeping Bruxism Treatment industry is projected to grow from 663.47 USD Million in 2025 to 1230.43 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.44% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Sleeping Bruxism Treatment Market is poised for growth driven by technological advancements and increasing awareness.

  • Technological advancements in treatment options are reshaping the Sleeping Bruxism Treatment Market, particularly in North America.
  • The rising demand for non-invasive treatments is evident, with dental splints remaining the largest segment.
  • In Asia-Pacific, the market is experiencing rapid growth, especially in the children segment.
  • Growing awareness of bruxism and increased investment in sleep health are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 616.69 (USD Million)
2035 Market Size 1230.43 (USD Million)
CAGR (2025 - 2035) 6.44%

Major Players

Johnson & Johnson (US), Procter & Gamble (US), GlaxoSmithKline (GB), Colgate-Palmolive (US), Bausch Health Companies (CA), Dentsply Sirona (US), Haleon (GB), Sunstar (JP), Oral-B (US)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Sleeping Bruxism Treatment Market Trends

The Sleeping Bruxism Treatment Market is currently experiencing a notable evolution, driven by a growing awareness of the condition and its potential health implications. As individuals increasingly recognize the adverse effects of bruxism, including dental damage and sleep disturbances, there is a rising demand for effective treatment options. This market encompasses a variety of solutions, ranging from dental devices to therapeutic interventions, which aim to alleviate symptoms and improve overall quality of life. Furthermore, advancements in technology and research are contributing to the development of innovative treatments, enhancing the efficacy and accessibility of care for those affected by this condition. In addition to the increasing awareness, the Sleeping Bruxism Treatment Market is influenced by a shift towards holistic approaches in healthcare. Patients are seeking comprehensive solutions that not only address the symptoms but also target underlying causes such as stress and anxiety. This trend is prompting healthcare providers to adopt multidisciplinary strategies, integrating behavioral therapies and lifestyle modifications alongside traditional treatments. As the market continues to evolve, it appears poised for growth, with potential opportunities for new entrants and established players alike to cater to the diverse needs of consumers seeking relief from bruxism-related issues.

Technological Advancements in Treatment Options

The Sleeping Bruxism Treatment Market is witnessing a surge in technological innovations, particularly in the development of custom-fitted dental devices. These advancements enhance comfort and effectiveness, making it easier for patients to manage their condition. Additionally, the integration of digital platforms for monitoring and managing bruxism symptoms is becoming more prevalent, allowing for personalized treatment plans.

Increased Focus on Mental Health

There is a growing recognition of the link between bruxism and mental health issues, such as stress and anxiety. This awareness is driving the Sleeping Bruxism Treatment Market towards more comprehensive treatment approaches that incorporate psychological support. Healthcare providers are increasingly offering therapies that address both the physical and emotional aspects of bruxism.

Rising Demand for Non-Invasive Treatments

Consumers are showing a preference for non-invasive treatment options within the Sleeping Bruxism Treatment Market. This trend reflects a broader shift towards less aggressive interventions, with patients seeking solutions that minimize discomfort and recovery time. As a result, manufacturers are focusing on developing products that align with this demand, such as mouthguards and relaxation techniques.

Sleeping Bruxism Treatment Market Drivers

Market Growth Projections

The Global Sleeping Bruxism Treatment Market Industry is projected to experience substantial growth over the coming years. With an estimated market value of 0.5 USD Billion in 2024, the industry is expected to expand significantly, reaching 1.23 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 8.54% from 2025 to 2035. Factors contributing to this expansion include increasing awareness of bruxism, advancements in treatment technologies, and rising dental care expenditures. The market's trajectory suggests that it will continue to evolve, driven by both consumer demand and innovations in treatment methodologies.

Rising Dental Care Expenditure

An increase in global dental care expenditure is a significant driver for the Global Sleeping Bruxism Treatment Market Industry. As individuals prioritize oral health and invest in preventive care, the demand for bruxism treatments is likely to rise. According to recent data, dental spending is projected to grow, reflecting a broader trend towards health-conscious consumer behavior. This increase in expenditure may lead to higher adoption rates of dental appliances and therapies for bruxism, contributing to the market's anticipated growth. The market is expected to reach 0.5 USD Billion in 2024, with further expansion anticipated as awareness and spending continue to rise.

Increasing Awareness of Bruxism

The rising awareness of bruxism as a prevalent dental disorder is a key driver for the Global Sleeping Bruxism Treatment Market Industry. As more individuals recognize the symptoms and potential consequences of untreated bruxism, the demand for effective treatments is likely to increase. Educational campaigns by dental associations and healthcare providers have contributed to this awareness, leading to a projected market value of 0.5 USD Billion in 2024. This heightened awareness may encourage patients to seek professional help, thereby expanding the market for various treatment options, including dental guards and behavioral therapies.

Integration of Behavioral Therapies

The integration of behavioral therapies into treatment plans for bruxism is emerging as a crucial driver for the Global Sleeping Bruxism Treatment Market Industry. Techniques such as cognitive-behavioral therapy and stress management strategies are being recognized for their effectiveness in reducing bruxism symptoms. This holistic approach not only addresses the physical aspects of bruxism but also its psychological triggers, appealing to a broader patient demographic. As healthcare providers increasingly adopt these therapies, the market is likely to experience growth, with projections indicating a market value of 1.23 USD Billion by 2035, driven by the comprehensive management of bruxism.

Growing Incidence of Stress and Anxiety

The increasing prevalence of stress and anxiety disorders globally is contributing to the rise in bruxism cases, thereby impacting the Global Sleeping Bruxism Treatment Market Industry. Stress is a known trigger for bruxism, and as mental health awareness grows, more individuals are likely to seek treatment for associated symptoms. This correlation suggests that as stress levels rise, so too will the demand for bruxism treatments. Consequently, the market is poised for growth, with estimates indicating a potential market value of 1.23 USD Billion by 2035, driven by the need for effective management strategies for stress-related bruxism.

Technological Advancements in Treatment Options

Technological innovations in dental care are significantly influencing the Global Sleeping Bruxism Treatment Market Industry. The introduction of advanced dental appliances, such as custom-fitted night guards and biofeedback devices, enhances treatment efficacy and patient comfort. These innovations not only improve patient outcomes but also attract more individuals to seek treatment. As the market evolves, the integration of digital health solutions, such as mobile applications for monitoring bruxism, is expected to further drive growth. This trend aligns with the projected market expansion to 1.23 USD Billion by 2035, reflecting a compound annual growth rate of 8.54% from 2025 to 2035.

Market Segment Insights

By Treatment Type: Behavioral Therapy (Largest) vs. Dental Splints (Fastest-Growing)

In the Sleeping Bruxism Treatment Market, the segment values exhibit distinctive market share distributions. Behavioral therapy holds the largest share as practitioners emphasize psychological approaches to mitigate bruxism. This is complemented by dental splints, which have gained increasing popularity for their immediate protective benefits. Meanwhile, medications, physical therapy, and stress management represent smaller yet significant shares, reflecting their supporting roles in comprehensive treatment plans. The growth trends in this segment are primarily driven by escalating awareness of bruxism's effects on dental health and well-being. Behavioral therapy continues to dominate as it addresses root causes through cognitive adjustment. However, dental splints are emerging rapidly as they provide direct mechanical support, appealing particularly to those seeking quick relief. This juxtaposition indicates a diverse approach to treatment, accommodating various patient preferences and needs.

Behavioral Therapy (Dominant) vs. Dental Splints (Emerging)

Behavioral therapy is the dominant force in the Sleeping Bruxism Treatment Market as it focuses on addressing the psychological and situational triggers of bruxism. This treatment form involves cognitive-behavioral strategies aimed at altering the habits that lead to teeth grinding. Its comprehensive nature highlights its long-term value in managing symptoms effectively. Conversely, dental splints are gaining traction as an emerging treatment option, providing a more immediate, physical solution for those suffering from acute bruxism. These appliances safeguard teeth against damage while patients work on underlying issues through therapy or other methods. As more users become aware of dental splints' effectiveness, their popularity is expected to rise, creating a dynamic interplay between these two approaches.

By Age Group: Children (Largest) vs. Adults (Fastest-Growing)

In the Sleeping Bruxism Treatment Market, the distribution of market share across age groups shows that children hold a significant portion, largely due to the high prevalence of bruxism in this demographic. This is often attributed to factors such as stress, misaligned teeth, or developmental issues that manifest during childhood, making them a focal point for treatment initiatives. Meanwhile, the adult population is increasingly facing bruxism as a result of mounting stress and anxiety levels in modern lifestyles, leading to a growing demand for tailored treatment options. The growth trends indicate that while children remain the largest segment, adults are emerging as the fastest-growing group. Changes in lifestyle, including increased employment-related stressors and anxiety, have triggered a spike in bruxism cases among adults. Additionally, the rising awareness of the dental complications associated with untreated bruxism is fostering a larger market for innovative treatment solutions targeting this age group, including therapies such as night guards and stress management techniques.

Children (Dominant) vs. Adults (Emerging)

In the market for sleeping bruxism treatments, children represent the dominant segment due to their higher exposure to the condition, resulting from various factors including dental misalignment and stress. Treatments for this demographic often focus on preventive measures and behavioral therapy, which cater specifically to younger patients. Conversely, adults constitute an emerging segment noted for their growing prevalence of bruxism driven by lifestyle changes. This group places greater importance on efficient and effective treatment methods, leading to increased demand for advanced products such as customizable night guards or dental prescriptions. As awareness of sleep disorders rises, adults are likely to seek solutions, making them essential players in the evolving market.

By Severity Level: Moderate (Largest) vs. Severe (Fastest-Growing)

In the Sleeping Bruxism Treatment Market, the segment distribution reveals that moderate severity cases represent the largest share, as they are the most commonly diagnosed among patients. With a significant number of individuals experiencing moderate symptoms, the treatment demand in this category is substantial, ensuring a wide variety of therapeutic options available to patients. Severe cases, while less frequent, are rapidly gaining market attention due to their notable impact on patients' quality of life, calling for advanced treatment modalities and innovations in management practices.

Severity: Moderate (Dominant) vs. Severe (Emerging)

The moderate severity segment stands as the dominant force in the Sleeping Bruxism Treatment Market, primarily due to its prevalence. Individuals in this category often experience noticeable grinding and discomfort, leading to increased awareness and proactive treatment approaches. They access a range of interventions, from simple lifestyle changes to custom nightguards. Conversely, the severe segment is classified as emerging, characterized by its urgent need for intensive management strategies, including pharmaceutical and therapeutic interventions. As awareness of the serious implications of severe bruxism grows, treatment options for this group are rapidly evolving, making it a focal point for new market entrants and existing key players alike.

By Diagnosis Method: Clinical Examination (Largest) vs. Electromyography (Fastest-Growing)

The Sleeping Bruxism Treatment Market showcases a notable distribution of diagnosis methods, with Clinical Examination holding the largest market share. This traditional method is widely utilized due to its cost-effectiveness and the ease of implementation in clinical settings. Patient History also plays a critical role, as it provides valuable insights into the behavior patterns of patients. Electromyography and Imaging Techniques are emerging as significant players, particularly in advanced diagnostics, with electroneurophysiological assessments gaining popularity for their precision and accuracy.

Clinical Examination (Dominant) vs. Electromyography (Emerging)

Clinical Examination remains the dominant method in the Sleeping Bruxism Treatment Market, primarily due to its accessibility and straightforward application in routine dental assessments. It allows practitioners to identify bruxism through visual and tactile methods, including checking for signs of tooth wear. On the other hand, Electromyography is an emerging technique, rapidly gaining traction for its ability to provide quantitative data about muscle activity associated with bruxism. While it requires specialized equipment, its precision and diagnostic capabilities are making it a preferred choice for specialists, thus gradually positioning it as a vital diagnostic tool in the field.

By Treatment Duration: Short-term (Largest) vs. Long-term (Fastest-Growing)

The distribution of market share within the Treatment Duration segment in the Sleeping Bruxism Treatment Market shows a notable preference for short-term treatments. Short-term solutions, which often include dental guards or behavioral therapies, dominate the market due to their immediate effects and accessibility. In contrast, medium-term and long-term treatments, while essential, account for a smaller share of the overall market. Long-term treatments, such as cognitive behavioral therapy, are gaining traction among consumers seeking more sustainable solutions.

Short-term (Dominant) vs. Long-term (Emerging)

Short-term treatments for sleeping bruxism, such as occlusal splints and behavioral modifications, are currently the dominant force in the market, appealing to consumers seeking quick relief from symptoms. These solutions are often recommended by dental professionals for their effectiveness in immediate symptom management and are supported by a wide range of marketing strategies emphasizing quick results. Conversely, long-term treatments represent an emerging trend, as increasing awareness about the underlying causes of bruxism drives patients towards comprehensive therapeutic approaches. These long-term strategies focus on addressing the root causes, such as stress management and sleep optimization, thereby positioning themselves as sustainable alternatives for enduring relief.

Get more detailed insights about Sleeping Bruxism Treatment Market
Request Free Sample

Regional Insights

North America : Market Leader in Treatment

North America is poised to maintain its leadership in the Sleeping Bruxism Treatment Market, holding a significant market share of $310.0 million as of 2024. The region's growth is driven by increasing awareness of sleep disorders, advancements in treatment options, and supportive healthcare policies. Regulatory bodies are actively promoting research and development, which further fuels market expansion. The rising prevalence of stress-related conditions also contributes to the growing demand for effective treatments. The competitive landscape in North America is robust, featuring key players such as GlaxoSmithKline, Pfizer, and Johnson & Johnson. These companies are investing heavily in innovative therapies and clinical trials to enhance their product offerings. The US sleeping bruxism treatment market stands out as the leading ecosystem, supported by a well-established healthcare infrastructure and a high rate of healthcare expenditure. This environment fosters collaboration between pharmaceutical companies and research institutions, ensuring a steady pipeline of new treatments.

Europe : Emerging Market Dynamics

Europe is witnessing a notable increase in the Sleeping Bruxism Treatment Market, with a market size of €180.0 million projected for December 2025. Factors such as rising awareness of oral health, increased stress levels, and a growing aging population are driving demand for effective treatment solutions. Regulatory frameworks in the region are becoming more supportive, encouraging innovation and ensuring that products meet high safety standards, which is crucial for consumer trust. Leading countries in Europe, such as Germany, France, and the UK, are at the forefront of this market. The competitive landscape includes major players like GlaxoSmithKline and Haleon, who are actively expanding their product lines. The presence of advanced healthcare systems and a focus on preventive care further enhance market opportunities, positioning Europe as a key player in the global landscape.

Asia-Pacific : Rapid Growth Potential

The Asia-Pacific region is emerging as a significant player in the Sleeping Bruxism Treatment Market, with a market size of $100.0 million anticipated by December 2025. The growth is fueled by rising disposable incomes, increasing awareness of dental health, and a surge in stress-related disorders. Regulatory bodies are beginning to implement guidelines that promote safe and effective treatment options, which is essential for market growth and consumer confidence. Countries like Japan, Australia, and China are leading the charge in this market. The competitive landscape is characterized by the presence of key players such as Sunstar and Dentsply Sirona, who are focusing on product innovation and strategic partnerships. The growing emphasis on preventive healthcare and the expansion of dental services in urban areas are further driving market expansion in this region.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is gradually developing its Sleeping Bruxism Treatment Market, with a market size of $36.69 million projected for December 2025. The growth is primarily driven by increasing awareness of dental health issues and a rising prevalence of sleep disorders. Regulatory frameworks are evolving, which is essential for ensuring the safety and efficacy of treatment options available in the market, thus fostering consumer trust and market growth. Leading countries in this region include South Africa and the UAE, where there is a growing focus on improving healthcare infrastructure. The competitive landscape is still emerging, with opportunities for both local and international players to establish a foothold. Companies are beginning to invest in awareness campaigns and product development, aiming to cater to the unique needs of consumers in this diverse region.

Sleeping Bruxism Treatment Market Regional Image

Key Players and Competitive Insights

The Sleeping Bruxism Treatment Market is currently characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an increasing awareness of oral health, rising incidences of sleep disorders, and a growing demand for effective treatment options. Major players such as Johnson & Johnson (US), Procter & Gamble (US), and GlaxoSmithKline (GB) are strategically positioned to leverage these trends. Johnson & Johnson (US) focuses on innovation in dental care products, while Procter & Gamble (US) emphasizes consumer education and product accessibility. GlaxoSmithKline (GB) is investing in research and development to enhance its product offerings, thereby shaping a competitive environment that is increasingly reliant on innovation and consumer engagement.In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in a market that is moderately fragmented. The collective influence of these key players is significant, as they not only drive product development but also set industry standards that smaller companies must adhere to. This competitive structure allows for a diverse range of treatment options, catering to various consumer needs and preferences.
In November Procter & Gamble (US) announced the launch of a new line of night guards specifically designed for bruxism sufferers, incorporating advanced materials that enhance comfort and effectiveness. This strategic move is likely to strengthen their market position by addressing consumer demand for more effective and user-friendly solutions. The introduction of this product reflects a broader trend towards innovation in treatment options, which is essential for maintaining competitive advantage in this sector.
In October GlaxoSmithKline (GB) revealed a partnership with a leading technology firm to develop an AI-driven app aimed at monitoring bruxism symptoms. This initiative not only showcases GlaxoSmithKline's commitment to integrating technology into healthcare but also positions the company at the forefront of digital health solutions. The potential for real-time data collection and personalized treatment plans could significantly enhance patient outcomes and engagement.
In September Johnson & Johnson (US) expanded its product line by acquiring a startup specializing in sleep health technologies. This acquisition is indicative of a strategic shift towards a more holistic approach to sleep-related disorders, suggesting that Johnson & Johnson (US) is keen on diversifying its offerings beyond traditional dental products. Such moves may enhance their competitive edge by providing comprehensive solutions that address the root causes of bruxism.
As of December current competitive trends in the Sleeping Bruxism Treatment Market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise to innovate more effectively. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift may redefine market dynamics, compelling companies to prioritize long-term value creation over short-term gains.

Key Companies in the Sleeping Bruxism Treatment Market include

Industry Developments

  • In January 2021, Henry Schein, Inc. acquired majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies. With this transaction, Henry Schein Medical, the US medical division of Henry Schein, Inc., enters an established and growing multibillion-dollar market for home medical equipment and supplies.
  • In June 2020, Carestream Dental entered into a partnership with Unified Smiles, a management consulting firm based in the US. Under the partnership, Carestream Dental will provide support, guidance, and education to independent practices.

Future Outlook

Sleeping Bruxism Treatment Market Future Outlook

The Sleeping Bruxism Treatment Market is projected to grow at a 6.44% CAGR from 2025 to 2035, driven by increasing awareness and advancements in treatment options.

New opportunities lie in:

  • Development of personalized oral appliances using 3D printing technology. Expansion of telehealth services for remote bruxism consultations. Investment in educational campaigns targeting dental professionals and patients.

By 2035, the market is expected to achieve substantial growth, reflecting evolving treatment methodologies and heightened consumer awareness.

Market Segmentation

Sleeping Bruxism Treatment Market Age Group Outlook

  • Children
  • Adolescents
  • Adults
  • Elderly

Sleeping Bruxism Treatment Market Severity Level Outlook

  • Mild
  • Moderate
  • Severe
  • Chronic

Sleeping Bruxism Treatment Market Treatment Type Outlook

  • Behavioral Therapy
  • Dental Splints
  • Medications
  • Botulinum Toxin Injections
  • Physical Therapy

Sleeping Bruxism Treatment Market Diagnosis Method Outlook

  • Clinical Examination
  • Patient History
  • Electromyography
  • Imaging Techniques

Sleeping Bruxism Treatment Market Treatment Duration Outlook

  • Short-term
  • Medium-term
  • Long-term

Report Scope

MARKET SIZE 2024 616.69(USD Million)
MARKET SIZE 2025 663.47(USD Million)
MARKET SIZE 2035 1230.43(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.44% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Johnson & Johnson (US), Procter & Gamble (US), GlaxoSmithKline (GB), Colgate-Palmolive (US), Bausch Health Companies (CA), Dentsply Sirona (US), Haleon (GB), Sunstar (JP), Oral-B (US)
Segments Covered Treatment Type, Age Group, Severity Level, Diagnosis Method, Treatment Duration
Key Market Opportunities Integration of digital therapeutics and personalized treatment plans in the Sleeping Bruxism Treatment Market.
Key Market Dynamics Rising consumer awareness and demand for effective treatments drive innovation in the sleeping bruxism treatment market.
Countries Covered North America, Europe, APAC, South America, MEA

Market Highlights

Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch
Leave a Comment

FAQs

What is the current valuation of the Sleeping Bruxism Treatment Market?

<p>The market valuation was 616.69 USD Million in 2024.</p>

What is the projected market size for the Sleeping Bruxism Treatment Market by 2035?

<p>The projected valuation for 2035 is 1230.43 USD Million.</p>

What is the expected CAGR for the Sleeping Bruxism Treatment Market during the forecast period?

<p>The expected CAGR for the market from 2025 to 2035 is 6.44%.</p>

Which treatment types are leading in the Sleeping Bruxism Treatment Market?

<p>Dental Splints and Medications are among the leading treatment types, with valuations of 184.99 to 370.43 USD Million and 123.34 to 246.09 USD Million, respectively.</p>

How does the market segment by age group?

<p>The market segments by age group, with Adults representing 400.0 to 800.0 USD Million, followed by Adolescents at 70.0 to 150.0 USD Million.</p>

What are the key players in the Sleeping Bruxism Treatment Market?

Key players include GlaxoSmithKline, Pfizer, Johnson &amp; Johnson, and Merck &amp; Co.

What is the market performance based on severity levels of bruxism?

The market shows notable performance in the Moderate and Severe categories, each valued between 184.99 and 369.98 USD Million.

What diagnostic methods are utilized in the Sleeping Bruxism Treatment Market?

Dental Imaging leads the diagnostic methods with a valuation of 246.69 to 390.43 USD Million.

How does behavioral therapy contribute to the market?

Behavioral Therapy contributes with a valuation range of 61.67 to 123.04 USD Million.

What trends are anticipated in the Sleeping Bruxism Treatment Market by 2035?

Trends suggest a continued growth trajectory, with increasing awareness and treatment options likely driving market expansion.

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory filings, peer-reviewed dental and sleep medicine journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health, European Medicines Agency (EMA), Health Canada, Therapeutic Goods Administration (TGA) Australia, and Pharmaceuticals and Medical Devices Agency (PMDA) Japan for device approvals and pharmacological regulations. Professional medical sources comprised the American Academy of Sleep Medicine (AASM), American Dental Association (ADA), European Sleep Research Society (ESRS), International Association for the Study of Pain (IASP), and the International Classification of Sleep Disorders (ICSD-3) registry. Academic databases included PubMed/MEDLINE, Cochrane Library, Sleep Medicine Reviews, Journal of Oral Rehabilitation, and Journal of Dental Research. Government health statistics were sourced from the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, National Institutes of Health (NIH) National Institute of Dental and Craniofacial Research (NIDCR), World Health Organization (WHO) Global Health Observatory and Oral Health Database, National Sleep Foundation, and EU Eurostat Health and Safety Data. These sources were used to collect bruxism prevalence statistics, polysomnography procedure volumes, regulatory approval data for mandibular advancement devices and pharmacological treatments, clinical safety studies on botulinum toxin injections for masseter hypertrophy, demographic trends in sleep disorders, and competitive landscape analysis for oral appliance therapy and drug-based interventions.

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consist of CEOs, VPs of Product Development, regulatory affairs heads, and commercial directors from dental device manufacturers (occlusal splint and mandibular advancement device producers), pharmaceutical companies that specialize in neuromuscular blockers and anxiolytics, sleep diagnostic equipment manufacturers, and polysomnography technology providers. Board-certified sleep medicine specialists, prosthodontists, oral and maxillofacial surgeons, neurologists who specialize in movement disorders, dental laboratory directors, procurement leads from sleep disorder centers, hospital dental departments, and specialized bruxism clinics comprised demand-side sources. Our primary research has confirmed the product pipeline timelines for novel muscle relaxants and smart dental devices, validated market segmentation across oral appliances, pharmacotherapy, and behavioral modalities, and gathered insights on the clinical adoption patterns of botulinum toxin versus traditional splint therapy, pricing strategies for custom-fabricated occlusal guards, reimbursement dynamics for sleep studies, and regional regulatory barriers for direct-to-consumer oral appliances.

Primary Respondent Breakdown:

• By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)

• By Region: North America (38%), Europe (25%), Asia-Pacific (28%), Rest of World (9%)

Market Size Estimation

Global market valuation was derived through revenue mapping and procedure volume analysis across dental therapeutic devices and pharmaceutical interventions. The methodology included:

• The identification of over 40 key manufacturers in North America, Europe, Asia-Pacific, and Latin America who specialize in the production of custom and prefabricated occlusal splints, mandibular advancement devices, botulinum toxin formulations, muscle relaxants, and sleep monitoring technologies.

• Product mapping across oral appliance therapy (hard/soft splints, stabilization splints, repositioning appliances), pharmacological segments (botulinum toxin type A, benzodiazepines, muscle relaxants), behavioral therapy platforms, and diagnostic devices (home sleep apnea tests, polysomnography equipment used in bruxism diagnosis)

• Analysis of reported and modeled annual revenues specific to nocturnal bruxism treatment portfolios, including dental laboratory service revenues associated with device fabrication

• Coverage of manufacturers representing 72-77% of global market share in 2024

• Extrapolation using bottom-up (procedure volume × ASP by country for sleep studies, splint fittings, and Botox injections) and top-down (manufacturer revenue validation and pharmaceutical prescription data analysis) approaches to derive segment-specific valuations for reversible versus irreversible treatment modalities

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization âś“ âś“ âś“
Direct Access to Analyst âś“ âś“ âś“
Deliverable Format âś“ âś“ âś“
Platform Access âś— âś— âś“
Discount on Next Purchase 10% 15% 15%
Printable Versions âś— âś— âś“